keyword
https://read.qxmd.com/read/38609536/predictive-value-of-18%C3%A2-f-fdg-pet-ct-versus-bone-marrow-biopsy-and-aspiration-in-pediatric-neuroblastoma
#1
JOURNAL ARTICLE
Zhenzhen Zhao, Chao Yang
BACKGROUND: Neuroblastoma (NB) is the most prevalent solid extracranial malignancy in children, often with bone marrow metastases (BMM) are present. The conventional approach for detecting BMM is bone marrow biopsy and aspiration (BMBA). 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography (18 F-FDG PET/CT) has become a staple for staging and is also capable of evaluating marrow infiltration. The consensus on the utility of 18 F-FDG PET/CT for assessing BMM in NB patients is still under deliberation...
April 13, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38607453/bilateral-adrenal-neuroblastoma-peculiar-pattern-of-a-rare-pediatric-presentation
#2
JOURNAL ARTICLE
Mohamed Fawzy, Gehad Ahmed, Yasser Youssef, Naglaa Elkinaai, Amal Refaat, Mai Amr Elahmadawy, Fadwa Said, Salma Elmenawi
BACKGROUND: Bilateral suprarenal neuroblastoma (BSN) is a rare presentation. Few previously published literature showed BSN patients to have favorable pattern and prognosis. This study aim was to evaluate clinical and biological features in relation to outcome of Egyptian patients with BSN. METHODS: Included patients were diagnosed from 2007 to 2017, retrospectively. Tissue biopsy, imaging and bone marrow were evaluated at presentation. Clinical, demographic, biological variables and risk group were determined and analyzed in relation to overall (OS) and event-free-survival (EFS)...
April 12, 2024: Discover. Oncology
https://read.qxmd.com/read/38604263/ovarian-tissue-biopsy-for-cryopreservation-by-vaginal-natural-orifice-transluminal-endoscopic-surgery-vnotes-a-new-approach-for-a-minimal-invasive-ovarian-biopsy
#3
JOURNAL ARTICLE
Renato Seracchioli, Manuela Maletta, Enrico Pazzaglia, Antonio Raffone, Rossella Vicenti, Stefano Scarperi, Valentino Bergamini, Diego Raimondo
OBJECTIVE: Vaginal natural orifice transluminal endoscopic surgery (vNOTES) is an emerging surgical procedure that combines the advantages of the vaginal approach with laparoscopic vision and instrumentation [1]. Shorter hospitalization and lower postoperative pain associated to vNOTES [2] may be explained by the advantages of this innovative surgical approach (such as absence of abdominal incisions, shorter operating time, lower insufflation pressure) [2;3]. Ovarian tissue cryopreservation allows to preserve reproductive and endocrine functions in young women with oncological disease at risk of premature ovarian insufficiency (POI) caused by gonadotoxic treatments [4]...
April 9, 2024: Fertility and Sterility
https://read.qxmd.com/read/38598875/development-and-validation-of-a-novel-nomogram-for-predicting-overall-survival-patients-with-neuroblastoma
#4
JOURNAL ARTICLE
Jin-du Zhao, Xian-Ying Lu, Tian-Ping Chen, Xian-Lun Duan, Wei Zuo, Kai Sai, Li-Ran Zhu, Qun Gao
PURPOSE: The aim of this study was to develop a nomogram specially for predicting overall survival (OS) for Chinese patients with neuroblastoma (NB). METHODS: Patients with pathologically confirmed NB who were newly diagnosed and received treatments at our hospital from October 2013 to October 2021 were retrospectively reviewed. The nomogram for OS were built based on Cox regression analysis. The validation of the prognostic model was evaluated by concordance index (C-index), calibration curves, and decision curve analyses (DCAs)...
April 6, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38590763/gd3-ganglioside-is-a-promising-therapeutic-target-for-glioma-patients
#5
REVIEW
Victoria Hein, Nathalie Baeza-Kallee, Alexandre Bertucci, Carole Colin, Aurélie Tchoghandjian, Dominique Figarella-Branger, Emeline Tabouret
Glioblastoma is the most frequent and aggressive primary brain tumor in adults. Currently, no curative treatment is available. Despite first-line treatment composed by the association of surgery, radiotherapy, and chemotherapy, relapse remains inevitable in a median delay of 6 to 10 months. Improving patient management and developing new therapeutic strategies are therefore a critical medical need in neuro-oncology. Gangliosides are sialic acid-containing glycosphingolipids, the most abundant in the nervous system, representing attractive therapeutic targets...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38556719/implementation-of-a-light-therapy-team-to-administer-photobiomodulation-therapy-a-standardized-protocol-to-prevent-and-treat-oral-mucositis-in-the-pediatric-hematopoietic-stem-cell-transplant-population
#6
JOURNAL ARTICLE
Kathleen Magee, Jenell Robins, Sharon Staton, Gabriella Llaurador, Alexandra M Stevens
BACKGROUND: Oral mucositis (OM) is a painful and common complication of hematopoietic stem cell transplant (HSCT). The Children's Oncology Group recently published guidelines recommending photobiomodulation (PBM) for preventing and treating OM in pediatric HSCT patients. However, this is a rarely used intervention in pediatric hospitals. PROCEDURE: Patients undergoing allogeneic HSCT, or autologous HSCT for a neuroblastoma diagnosis, had PBM administered from the first day of conditioning to transplant Day +20...
March 31, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38553363/a-randomised-phase-ii-trial-to-evaluate-the-feasibility-of-radiotherapy-dose-escalation-facilitated-by-intensity-modulated-arc-radiotherapy-techniques-in-high-risk-neuroblastoma
#7
JOURNAL ARTICLE
J E Gains, A Patel, Yen-Ch'ing Chang, H C Mandeville, G Smyth, C Stacey, J Talbot, K Wheatley, M N Gaze
BACKGROUND AND PURPOSE: For high-risk neuroblastoma, planning target volume coverage is often compromised to respect adjacent kidney tolerance. This trial investigated whether intensity-modulated arc radiotherapy techniques (IMAT) could facilitate dose escalation better than conventional techniques. MATERIALS AND METHODS: Children with high-risk abdominal neuroblastoma referred for radiotherapy to the primary tumour site and involved regional lymph nodes were randomised to receive either standard dose (21 Gy in 14 fractions) or escalated dose (36 Gy in 24 fractions) radiotherapy...
March 15, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists
https://read.qxmd.com/read/38526915/treatment-of-unilateral-olfactory-neuroblastoma-appropriate-extent-of-surgical-resection-and-potential-for-olfactory-preservation
#8
JOURNAL ARTICLE
Harish Dharmarajan, Garret Choby, Ralph Abi Hachem, Edward C Kuan, Corinna G Levine, Olabisi Sanusi, Theodore Schuman, Dennis Tang, Michael Yim, Mathew Geltzeiler
Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology...
March 25, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38519890/serum-cholesterol-level-as-a-predictive-biomarker-for-prognosis-of-neuroblastoma
#9
JOURNAL ARTICLE
Jie Min, Yi Wu, Shungen Huang, Yanhong Li, Xinjing Lv, Ruze Tang, He Zhao, Jian Wang
BACKGROUND: Neuroblastoma (NB), a type of solid tumor in children, has a poor prognosis. Few blood biomarkers can accurately predict the prognosis, including recurrence and survival, in children with NB. In this study, we found that the serum total cholesterol (Tchol) level was associated with the prognosis of patients through a retrospective study. METHODS: Multivariate Cox regression model was used to identify the independent risk factors in the children with NB...
March 22, 2024: BMC Pediatrics
https://read.qxmd.com/read/38518294/patterns-of-recurrence-and-disease-progression-in-patients-with-positive-margin-olfactory-neuroblastoma-following-primary-resection
#10
JOURNAL ARTICLE
Megan M J Bauman, Jeffrey P Graves, Travis J Haller, Ryan A McMillan, David M Routman, Aditya Raghunathan, Janalee K Stokken, Michael J Link, Eric J Moore, Garret Choby, Jamie J Van Gompel
OBJECTIVE: Olfactory neuroblastoma (ONB) is a rare, malignant tumor of the sinonasal tract that arises from olfactory epithelium. Although surgery is the preferred first-line treatment, tumor involvement of adjacent structures may preclude the ability to achieve negative margins during initial resection. Herein, the authors examine the oncological outcomes of patients with positive margins after primary resection of ONB, with the aim of determining predictors of disease progression and patterns of recurrence...
March 22, 2024: Journal of Neurosurgery
https://read.qxmd.com/read/38512513/integrative-analysis-with-machine-learning-identifies-diagnostic-and-prognostic-signatures-in-neuroblastoma-based-on-differentially-dna-methylated-enhancers-between-inss-stage-4-and-4s-neuroblastoma
#11
JOURNAL ARTICLE
Shan Li, Tao Mi, Liming Jin, Yimeng Liu, Zhaoxia Zhang, Jinkui Wang, Xin Wu, Chunnian Ren, Zhaoying Wang, Xiangpan Kong, Jiayan Liu, Junyi Luo, Dawei He
INTRODUCTION: Accumulating evidence demonstrates that aberrant methylation of enhancers is crucial in gene expression profiles across several cancers. However, the latent effect of differently expressed enhancers between INSS stage 4S and 4 neuroblastoma (NB) remains elusive. METHODS: We utilized the transcriptome and methylation data of stage 4S and 4 NB patients to perform Enhancer Linking by Methylation/Expression Relationships (ELMER) analysis, discovering a differently expressed motif within 67 enhancers between stage 4S and 4 NB...
March 21, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38510629/dural-reconstruction-with-or-without-a-bone-graft-of-paranasal-and-anterior-skullbase-malignancies-retrospective-single-center-analysis-of-11-cases-and-review-of-literature
#12
JOURNAL ARTICLE
Björn Sommer, Ina Konietzko, Maximilian Niklas Bonk, Tina Schaller, Bruno Märkl, Klaus Henning Kahl, Georg Stüben, Johannes Zenk, Ehab Shiban
INTRODUCTION: The reconstruction of frontobasal defects following oncologic resections of paranasal and anterior skull base (ASB) malignancies remains challenging. Ineffective reconstruction could lead to cerebrospinal fluid leak, meningitis, and tension pneumocephalus. RESEARCH QUESTION: Aim of this investigation was to analyse postoperative complication rates with or without bone graft for anterior skull base reconstruction. MATERIAL AND METHODS: In this retrospective study, we included patients following resection of paranasal and/or anterior skull base malignancies between October 2013 and December 2022...
2024: Brain Spine
https://read.qxmd.com/read/38490882/incidence-and-risk-factors-for-chyle-leaks-after-neuroblastic-tumor-resection-a-systematic-review-of-published-studies
#13
REVIEW
Arimatias Raitio, Paul D Losty
BACKGROUND: Chyle leakage/ascites after surgical resection of neuroblastic tumors may delay the start of chemotherapy and worsen prognosis. Previous studies have reported a highly variable incidence and risk factors remain largely unknown. This study aims to analyze the true incidence of chyle leaks and ascites and seeks to identify risk factors and optimal treatment strategies. METHODS: Medline/Embase databases were searched according to PRISMA guidelines. Literature reviews, case reports, and non-English papers were excluded...
February 26, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38489858/chemo-immunotherapy-with-dinutuximab-beta-in-patients-with-relapsed-progressive-high-risk-neuroblastoma-does-chemotherapy-backbone-matter
#14
JOURNAL ARTICLE
Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, Benoit Dumont, Anne-Sophie Defachelles, Estelle Thebaud, Julie Tandonnet, Claudia Pasqualini, Stéphanie Proust, Natacha Entz-Werle, Isabelle Aerts, Lee A Ndounga-Diakou, Arnaud Petit, Chloe Puiseux, Camille Khanfar, Jeremie Rouger, Ludovic Mansuy, Joy Benadiba, Frédéric Millot, Claire Pluchart, Salim Laghouati, Birgit Geoerger, Gilles Vassal, Dominique Valteau-Couanet, Pablo Berlanga
BACKGROUND: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this indication. This study presents the chemo-immunotherapy experience in patients with relapsed/progressive high-risk neuroblastoma treated within the off-label use program of the Neuroblastoma Committee of the French Society of Pediatric Oncology (SFCE)...
May 2024: European Journal of Cancer
https://read.qxmd.com/read/38478912/incidence-survival-and-mortality-of-cancer-in-children-and-young-adolescents-in-belgium-and-the-netherlands-in-2004-2015-a-comparative-population-based-study
#15
JOURNAL ARTICLE
Hanne Peirelinck, Maya Schulpen, Raoull Hoogendijk, An Van Damme, Rob Pieters, Kris Henau, Nancy Van Damme, Henrike E Karim-Kos
International comparisons of cancer surveillance measures may provide insight into inequalities in registration practices, etiological factors, and treatment strategies. This study aimed to compare incidence, survival, and mortality of cancer in children and young adolescents between Belgium and the Netherlands. All children (0-14 years) and young adolescents (15-17 years) diagnosed with cancer between 2004 and 2015 were selected from the population-based cancer registries of Belgium (N = 4739) and the Netherlands (N = 7322)...
March 13, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38473329/anti-pd-1-therapy-in-advanced-pediatric-malignancies-in-nationwide-study-good-outcome-in-skin-melanoma-and-hodgkin-lymphoma
#16
JOURNAL ARTICLE
Agata Marjańska, Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek, Monika Drogosiewicz, Bożenna Dembowska-Bagińska, Katarzyna Bobeff, Wojciech Młynarski, Katarzyna Adamczewska-Wawrzynowicz, Jacek Wachowiak, Małgorzata A Krawczyk, Ninela Irga-Jaworska, Jadwiga Węcławek-Tompol, Krzysztof Kałwak, Małgorzata Sawicka-Żukowska, Maryna Krawczuk-Rybak, Anna Raciborska, Agnieszka Mizia-Malarz, Agata Sobocińska-Mirska, Paweł Łaguna, Walentyna Balwierz, Jan Styczyński
BACKGROUND/AIM: The role of immune checkpoint inhibitors (ICIs; anti-PD1) in the treatment of childhood cancers is still evolving. The aim of this nationwide retrospective study was to assess the safety and effectiveness of ICIs used in a group of 42 patients, with a median age of 13.6 years, with various types of advanced malignancies treated in pediatric oncology centers in Poland between 2015 and 2023. RESULTS: The indications for treatment with anti-PD1 were as follows: Hodgkin lymphoma (11); malignant skin melanoma (9); neuroblastoma (8); and other malignancies (14)...
February 28, 2024: Cancers
https://read.qxmd.com/read/38461108/multi-modal-3-dimensional-visualization-of-pediatric-neuroblastoma-aiding-surgical-planning-beyond-anatomical-information
#17
JOURNAL ARTICLE
Dominique C Simons, Myrthe A D Buser, Matthijs Fitski, Cornelis P van de Ven, Bernhard Ten Haken, Marc H W A Wijnen, Can Ozan Tan, Alida F W van der Steeg
BACKGROUND: Patient-specific 3D models of neuroblastoma and relevant anatomy are useful tools for surgical planning. However, these models do not represent the heterogenous biology of neuroblastoma. This heterogeneity is visualized with the ADC and 123 I-MIGB-SPECT-CT imaging. Combining these multi-modal data into preoperative 3D heatmaps, may allow differentiation of the areas of vital and non-vital tumor tissue. We developed a workflow to create multi-modal preoperative 3D models for neuroblastoma surgery...
February 24, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38433161/use-of-pedicled-flaps-after-oncologic-resections-in-pediatric-patients
#18
REVIEW
María Dolores Blanco, Manuel de la Torre, Concepción Lorca, Agustín Del Cañizo, Isabel Bada, Sara Monje, María Antonia García-Casillas, Ángel Villa, Elena de Tomás, Beatriz Berenguer
The aim of this study is to review the indications of pedicled flaps and analyze the results. A observational retrospective study of under 18-year-old oncology patients who required reconstructive surgery with pedicled flaps between 2011 and 2022 was performed. Demographic and clinical variables, indications, complications, and outcomes were collected. 236 patients were reviewed and 13 met inclusion criteria, eight girls and five boys (mean age: 10.6 years). Indications were Ewing's sarcoma (5), osteosarcoma (5), neuroblastoma, desmoid tumor, and neurofibroma...
March 3, 2024: Pediatric Surgery International
https://read.qxmd.com/read/38427078/integrated-machine-learning-driven-disulfidptosis-profiling-cyfip1-and-emilin1-as-therapeutic-nodes-in-neuroblastoma
#19
JOURNAL ARTICLE
Zhang Mengzhen, Hou Xinwei, Tan Zeheng, Li Nan, Yang Yang, Yang Huirong, Fan Kaisi, Ding Xiaoting, Yang Liucheng, Wu Kai
BACKGROUND: Neuroblastoma (NB), a prevalent pediatric solid tumor, presents formidable challenges due to its high malignancy and intricate pathogenesis. The role of disulfidptosis, a novel form of programmed cell death, remains poorly understood in the context of NB. METHODS: Gaussian mixture model (GMM)-identified disulfidptosis-related molecular subtypes in NB, differential gene analysis, survival analysis, and gene set variation analysis were conducted subsequently...
March 1, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38418146/development-of-a-simple-and-reproducible-cell-derived-orthotopic-xenograft-murine-model-for-neuroblastoma
#20
JOURNAL ARTICLE
Kathleen Doyle, Abd-Elrahman Hassan, Maria Sutter, Monica Rodriguez, Priyadarsini Kumar, Erin Brown
BACKGROUND/AIM: Neuroblastoma is a common childhood cancer with poor survival for children with high-risk disease, and ongoing research to improve outcomes is needed. Patient-derived xenografts (PDX) and genetically engineered mouse models (GEMM) are reliable models for oncologic research; however, they are resource-intensive, expensive, and require significant expertise to develop and maintain. We developed an orthotopic xenograft murine model of neuroblastoma that utilizes cryopreserved banks of human neuroblastoma cell lines, requires minimal equipment, and is easily reproducible...
2024: In Vivo
keyword
keyword
171574
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.